Protagonist Therapeutics (PTGX) Stock Chart & Stock Price History $46.04 +0.24 (+0.53%) As of 03:09 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Protagonist Therapeutics Stock Price Performance 5 Day Performance+9.00%1 Month Performance-12.37%3 Month Performance+26.17%6 Month Performance-1.20%Year-To-Date Performance+20.35%1 Year Performance+81.68% Receive PTGX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address PTGX Stock Chart for Thursday, April, 17, 2025 PTGX Chart by TradingViewRemove Ads Protagonist Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/16/2025$46.95$45.80-2.45%$47.14$45.001.33 million shs$2.81 billion04/15/2025$45.03$46.95+4.26%$48.32$44.972.15 million shs$2.88 billion04/14/2025$42.62$45.03+5.65%$45.51$42.531.16 million shs$2.76 billion04/11/2025$40.89$42.62+4.23%$42.63$41.101.16 million shs$2.62 billion04/10/2025$42.57$40.89-3.95%$43.00$39.901.64 million shs$2.51 billion04/09/2025$41.67$42.57+2.16%$43.91$39.601.87 million shs$2.61 billion04/09/2025$41.67$42.57+2.16%$43.91$39.601.87 million shs$2.61 billion04/08/2025$43.21$41.67-3.56%$45.88$40.882.07 million shs$2.56 billion04/08/2025$43.21$41.67-3.56%$45.88$40.882.07 million shs$2.56 billion04/07/2025$44.44$43.21-2.77%$45.32$42.441.59 million shs$2.65 billion Get the Latest News and Ratings for PTGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/04/2025$46.50$44.44-4.43%$46.45$43.931.75 million shs$2.73 billion04/03/2025$48.20$46.50-3.53%$47.25$45.791.48 million shs$2.85 billion04/02/2025$46.88$48.20+2.82%$48.93$46.391.22 million shs$2.96 billion04/01/2025$48.36$46.88-3.06%$48.68$46.541.10 million shs$2.88 billion03/31/2025$48.88$48.36-1.06%$48.80$47.091.21 million shs$2.97 billion03/28/2025$49.44$48.88-1.13%$50.48$48.80664,503 shs$3.00 billion03/27/2025$49.56$49.44-0.24%$50.52$49.33715,396 shs$3.03 billion03/26/2025$51.05$49.56-2.92%$51.40$49.40881,894 shs$3.04 billion03/25/2025$52.53$51.05-2.82%$53.58$50.72790,374 shs$3.13 billion03/24/2025$52.65$52.53-0.23%$53.70$51.611.52 million shs$3.22 billion03/21/2025$53.05$52.65-0.75%$53.23$51.063.70 million shs$3.23 billion03/20/2025$54.35$53.05-2.39%$54.11$52.47890,942 shs$3.26 billion03/19/2025$54.52$54.35-0.31%$54.54$52.431.05 million shs$3.34 billion03/18/2025$53.01$54.52+2.85%$54.55$51.84784,643 shs$3.35 billion03/17/2025$54.78$53.01-3.23%$54.25$52.261.28 million shs$3.25 billion Related Companies Dr. Reddy's Laboratories Stock Price Chart Moderna Stock Price Chart Viatris Stock Price Chart Qiagen Stock Price Chart Ascendis Pharma A/S Stock Price Chart Roivant Sciences Stock Price Chart Lantheus Stock Price Chart TG Therapeutics Stock Price Chart Revolution Medicines Stock Price Chart BridgeBio Pharma Stock Price Chart Receive PTGX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTGX) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagonist Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protagonist Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
